We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

SEBIA

Sebia provides clinical protein electrophoresis equipment and reagents for in-vitro diagnostic testing, including sys... read more Featured Products: More products

Download Mobile App




Capillary Electrophoresis Evaluated for Hemoglobinopathy Testing

By LabMedica International staff writers
Posted on 25 May 2015
The detection of structural hemoglobin (Hb) variants and thalassemia has become increasingly important in clinical laboratories of all countries with a large influx of immigrants over the past 10 years.

Guidelines for hemoglobinopathy screening not only recommend the use of quantitative techniques for thalassemia detection, they also stress the use of a confirmatory method when an Hb variant is detected. More...
In an ideal setting, both techniques can be met by a combination of high-performance liquid chromatography (HPLC) and capillary zone electrophoresis (CZE).

Scientists at the University Hospital Leuven (Belgium) and their colleagues evaluated a suitable stand-alone method for hemoglobinopathy screening of approximately 50 clinical samples a week. The studied the analytical performance of a CZE and set up a comparison with two well-established HPLC methods.

Capillary zone electrophoresis was performed using the Minicap Flex Piercing CZE system (Sebia; Norcross, GA, USA). The instrument is equipped to resuspend, lyse, separate, and analyze whole blood samples for variants collected in ethylenediaminetetraacetic acid (EDTA) tubes. The lysed red cells are electrophoresed in alkaline buffer (pH 9.4) allowing separation to be directed by pH and endosmosis. Detection of eluting hemoglobin species is accomplished using the change in absorbance at 415 nm. CZE does not require daily calibration, but normal HbA and HbA2 migration controls are analyzed daily through each capillary before additional quality control (QC), or patient samples are run to ensure proper charge and function of both capillaries. The two well-established HPLC methods were the Bio-Rad Variant Classic and the Bio-Rad D-10 instruments (Bio-Rad Laboratories; Hercules, CA, USA).

The analytical performance was acceptable for the determination of HbA, HbA2, HbS, and HbF, with an imprecision equal to or less than 2.0%. Method comparison showed a linear correlation for HbA2, HbF, and HbS measurements. Clinical concordance was acceptable when comparing CZE and HPLC. Hb variant presumptive identification was evaluated by analyzing seven samples with confirmed heterogeneous or homogeneous presence of Hb variants: two HbC, one HbD, one HbE and HbA2'. One sample was compound heterogeneous for HbS and HbC. On the Minicap Flex Piercing, a minimal overlap between HbC and HbA2 was found.

The authors concluded that as HPLC methods have the advantage of a great precision in detection of a large number of variants, it has the disadvantage of a complex elution pattern that may be difficult to interpret for many routine chemistry laboratories. The Minicap Flex Piercing showed similar analytical performance compared to previous published work using CZE. As for HPLC, CZE gives only a provisional identification of variant hemoglobins, and confirmation by an alternative method based on a different principle is needed. The study was published in the June 2015 issue of the International Journal of Laboratory Hematology.

Related Links:

University Hospital Leuven
Sebia 
Bio-Rad Laboratories 



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Sample Transportation System
Tempus1800 Necto
New
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.